These findings encouraged us to explore the possibility of developing a combination therapy of suppressing the infiltration of both macrophages and microglia via inhibition of LOX and CLOCK-OLFML3 axis (13, 20) in PTEN-deficient GBM mouse models. This evidence concerns the gene PTEN and glioblastoma.